Celltrion
Celltrion is a South Korean biopharmaceutical company headquartered in Incheon, South Korea. It was founded in 2002 by Jung Jin Seo. The company specializes in the development, manufacturing, and marketing of biosimilars and biopharmaceuticals. Celltrion is known for its innovative approach to biotechnology and has made significant contributions to the global healthcare industry.
History
Celltrion was established in 2002 with the aim of developing biosimilars, which are biologic medical products highly similar to already approved reference products. The company quickly gained recognition for its high-quality biosimilars and expanded its operations globally.
Products
Celltrion's product portfolio includes a range of biosimilars and biopharmaceuticals. Some of the notable products include:
- Remsima (infliximab): A biosimilar to Remicade, used to treat autoimmune diseases such as rheumatoid arthritis and Crohn's disease.
- Truxima (rituximab): A biosimilar to Rituxan, used in the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
- Herzuma (trastuzumab): A biosimilar to Herceptin, used in the treatment of HER2-positive breast cancer.
Research and Development
Celltrion invests heavily in research and development (R&D) to innovate and improve its product offerings. The company operates state-of-the-art R&D facilities and collaborates with various academic and research institutions to advance its biopharmaceutical technologies.
Global Presence
Celltrion has a strong global presence, with subsidiaries and partnerships in various countries. The company exports its products to numerous markets, including the United States, Europe, and Asia. Celltrion's global expansion strategy focuses on increasing accessibility to affordable biosimilars and improving healthcare outcomes worldwide.
Awards and Recognition
Celltrion has received numerous awards and accolades for its contributions to the biopharmaceutical industry. The company is recognized for its commitment to quality, innovation, and patient care.
See Also
- Biopharmaceutical
- Biosimilar
- Incheon
- Rheumatoid arthritis
- Crohn's disease
- Non-Hodgkin's lymphoma
- Chronic lymphocytic leukemia
- HER2-positive breast cancer
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
